SECsense Logo

Ultragenyx Pharmaceutical Inc. 8-K Report: Key Updates for December 19, 2024

$RARE
Form 8-K
Filed on: 2024-12-19
Source
Ultragenyx Pharmaceutical Inc. 8-K Report: Key Updates for December 19, 2024

Based on the provided XML section of a financial report, here are the key insights and important information extracted:

  1. Entity Information:
  • Company Name: Ultragenyx Pharmaceutical Inc.
  • CIK (Central Index Key): 0001515673
  • IRS Employer Identification Number (EIN): 27-2546083
  • Address: 60 Leveroni Court, Novato, CA 94949
  • Phone Number: 415-483-8800
  1. Filing Information:
  • Form Type: 8-K (Current Report)
  • Filing Date: December 19, 2024
  1. Stock Information:
  • Class of Stock: Common Stock
  • Par Value: $0.001
  • Ticker Symbol: RARE
  • Exchange: NASDAQ
  1. Period of Report:
  • Report Date: The report covers a single day, December 19, 2024.
  1. Schema Reference:
  • The filing utilizes an XBRL schema reference indicating a structured format for reporting financial information.

Summary

Ultragenyx Pharmaceutical Inc. has filed an 8-K report dated December 19, 2024. The company is publicly traded under the ticker symbol RARE on NASDAQ, with a par value of $0.001 for its common stock. The report is prepared in compliance with SEC regulations and is structured using XBRL for standardization.

This type of filing typically includes significant events or corporate changes that may affect the company's financial position or operations. Further details would likely be found in the full 8-K report.